Sorafenib Nexavar

Sorafenib Nexavar

This chemotherapy and cancer drugs article is about Sorafenib (Nexavar) which is a treatment for advanced kidney cancer.  It is a type of biological therapy, called a protein tyrosine kinase inhibitor (TKI). Tyrosine kinase is a protein which acts as a chemical messenger that encourages cancer cells to grow.  Sorafenib blocks these proteins and thus stops the cancer creating blood vessels (anti-angiogenesis).  It is currently being researched for use with liver cancer.

Research published in the NCI Cancer Bulletin, in 2007 showed that sorafenib also  improves the survival of patients with advanced liver cancer. It is taken in tablet form.

Side effects are generally mild and can include:  diarrhoea, soreness and redness in the palm and soles, fatigue, skin rashes, hair thinning, nausea, bruising and bleeding, raised blood pressure, increased risk of infection, loss of appetite, constipation, aches and pains.

Other articles that you may find interesting are:

  1. Diet for Chemotherapy ;
  2. Beneficial bacteria ;
  3. A-Z guide to complementary therapies;
  4. Your cancer, where you can read about everything from causes to cancer treatments to complementary therapies for your cancer.
  5. How to boost your immune system.

To return to the drug list, click here.


Learn about your cancer drugs.
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our

Join Our Newsletter Signup today for free and be the first to get notified on new updates.